CCND1 and cancer: It induced cell cycle arrest at the G0/G1 and G2/M phases by activating P21, P27, Bax, cyclin E, and decreasing cyclin D1 consequently downregulating cyclin-dependent kinases such as CDK1,CDK2,CDK4, and CDK6 in various cancer cell lines (83–86).